Study limitation: The 2 million figure refers to fill attempts, not unique individuals (1.17 million patients); sample size tag reflects attempts as the primary unit of analysis | ReachRx
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States
Study limitation reported by the research below: “The 2 million figure refers to fill attempts, not unique individuals (1.17 million patients); sample size tag reflects attempts as the primary unit of analysis.”
